Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-17,917
Closed -$531K 360
2023
Q3
$531K Sell
17,917
-12,753
-42% -$427K 0.07% 269
2023
Q2
$1.08M Buy
30,670
+2,868
+10% +$80.2K 0.14% 196
2023
Q1
$669K Buy
27,802
+11,962
+76% +$277K 0.11% 216
2022
Q4
$352K Sell
15,840
-4,325
-21% -$100K 0.03% 280
2022
Q3
$479K Sell
20,165
-17,148
-46% -$462K 0.05% 240
2022
Q2
$867K Buy
37,313
+27,072
+264% +$729K 0.08% 170
2022
Q1
$420K Buy
+10,241
New +$534K 0.03% 264

Other funds holding CFLT

Advisory Research's CFLT Position: Q4 2023 in Review

Advisory Research sold out of Confluent (CFLT) in Q4 2023, closing a stake of 17,917 shares — an estimated $531K sold.

Advisory Research first reported a position in CFLT in Q1 2022 and held it in 7 quarters. The position peaked at $1.08M in Q2 2023. 365 funds tracked by Wall St. Rank hold CFLT as of Q4 2023.

  • Advisory Research reported no remaining Confluent position as of Q4 2023 after selling out during the quarter.
  • Advisory Research sold 17,917 Confluent shares in Q4 2023, an estimated $531K.
  • Advisory Research first reported a position in Confluent in Q1 2022 and held it in 7 quarters.
  • Advisory Research's Confluent position peaked at $1.08M in Q2 2023.
  • 365 funds tracked by Wall St. Rank held Confluent as of Q4 2023.

Based on Advisory Research's 13F filing for Q4 2023, filed 13 Feb 2024.